Aussie Macro Moment. Budget 16/17 careful consolidation AUSTRALIA. Event. Impact. Outlook

Similar documents
Healthcare. Currency adjustments AUSTRALIA. Event. Impact. Outlook COH 8.0% RMD 6.9% CSL 6.0% ANN 5.0% SHL 2.6%

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation

Australian Banks. Money Talks vertically challenged AUSTRALIA. Inside. Majors average short positions and banks index

Platinum Asset Management

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.

Australian Banks. Insolent Insolvencies

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

SG Fleet Group. Another UK acquisition. Earnings and target price revision

US Economics. State of the Union Growth, rates, and equities NORTH AMERICA. In a nutshell. Our key views on growth, policy, and rates

Australian Mobile Market

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Australian Banks. Funding markets open for now

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

AMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Generation Healthcare REIT

Builders Barometer. Rising damp AUSTRALIA. Event. Impact. Outlook

NIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

SingTel. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Outperform.

Bendigo and Adelaide Bank

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation

Aust. General Insurance

National Australia Bank

Auckland International Airport

Automotive Holdings Group

Whitehaven Coal. China outlook drives impairments A$1.04 AUSTRALIA. Event. Impact. Earnings and target price revision.

Vista Group International

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Australian Banks. If it s too good to be true AUSTRALIA. Event. Impact. Outlook. Impact of repricing and capital from additional 10% investor RWA

Oil Search. Proving up PNG A$7.11 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Sims Metal Management

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Tox Free Solutions. Winning work again A$2.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Ramsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Aventus Retail Property Fund

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Fisher & Paykel Healthcare

Coca-Cola Amatil. Not as fizzy as it looks A$8.78 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Cochlear. Roberts replaced A$88.66 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Meridian Energy. On tax depreciation NZ$2.08 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Senex Energy Production and revenue unsurprised, cash builds on lower capex

Oz Minerals. On track to meet guidance A$6.51 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

ANZ Bank. The Dis-Associates. Earnings and target price revision. No change. Price catalyst. Catalyst: 3Q15 Trading Update. Action and recommendation

Sirtex Medical. Healthy dose sales. Earnings and target price revision. Price catalyst. Catalyst: FY16 result on the 24th of August

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation

The Carbon Tax. Macquarie Funds Group. Implications for the Economy AUSTRALIA. Event. Impact. Outlook. 11 July 2011

Oz Minerals. Solid start to the year A$5.62 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

NEW ZEALAND Price Valuation NZ$ 1.74 Event 12-month target NZ$ month TSR % -10.1

National Australia Bank

Origin Energy. 4Q Production. ORG reported its 4 th quarter production report, following on ConocoPhilips quarterly result.

Telstra Corporation. Vodafone better, but far from good A$6.43 AUSTRALIA. Event. Impact. Earnings and target price revision.

Nuplex Industries. Should benefit from a weak Kiwi NZ$4.55 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Super Retail Group (SUL AU) Are we there yet?

Genworth Mortgage Insurance Australia

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook

Australia without mining

Southern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA

Austal. Retail take up 62% Earnings and target price revision. Price catalyst. Action and recommendation

Kingsgate Consolidated

Billabong International

Orocobre. Upside exposure fading. Earnings and target price revision. Price catalyst. Catalyst: Update on projects or Q1 report

Iron Mountain. US$10 worth Recalling at investor day US$31.83 UNITED STATES. Event. Impact. Earnings and target price revision.

Commodities Comment. Xiongan A new city with new metals demand GLOBAL. Feature article. Latest news

Carsales.com. Motoring along nicely A$10.23 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Spotless Group Holdings

ANZ Bank. What execution risk? Earnings and target price revision. Price catalyst. Catalyst: 1Q17 Trading update, February 2017.

Fisher & Paykel Healthcare

SingTel. Optus rises A$3.98 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Karoon Gas. What a difference a day makes A$1.63 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Generation Healthcare REIT All about spread Event

Perseus Mining. Revised Sissingué plan A$0.31 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

PanAust. Larger impairment and dividend cut A$1.35 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

CSL: Global plasma report

CIMIC Group. Earnings and target price revision. No change. Price catalyst. Catalyst: Q1 earnings 13 April. Action and recommendation

Commodities Comment. PGM cost curve another difficult year for S. African miners GLOBAL. Feature article. Latest news

Fortescue Metals Group

Downer EDI Two out of three ain t bad Event

Genesis Energy. A 9% FCF yield and you call underperform? NZ$1.71 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Regis Resources. Strong 1H15 result A$1.29 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Bendigo and Adelaide Bank

Fund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views

Coca-Cola Amatil. Earnings and target price revision. Price catalyst. Action and recommendation

Kiwi Property Group. Land banking for the future NZ$1.43 NEW ZEALAND. Event. Impact. Earnings and target price revision.

JB Hi-Fi & Harvey Norman

Dexus Property Group. Infra driving industrial demand A$9.94 AUSTRALIA. Event. Impact. Earnings and target price revision.

Earnings and target price revision. Price catalyst. Action and recommendation

Pilbara Minerals (PLS AU) Ramp-up gaining traction

Tatts Group. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Underperform on valuation grounds.

Sandfire Resources. Swings to net cash A$5.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

The quiet achiever. Earnings and target price revision. Price catalyst. Catalyst: July building approvals 30 August. Action and recommendation

3P Learning. Coming to America... A$2.55 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Commodities Comment. Chinese steel sentiment extremely positive ahead of peak season GLOBAL. Feature article. Latest news

AUSTRALIA Price Valuation A$ 7.52 Event 12-month target A$ month TSR % +3.4

Ramsay Health Care (RHC AU) RHC UK on the mend?

Independence Group NL

Premier Investments. Making a move? A$14.18 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Ryman Healthcare. Arrested development NZ$9.60 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst

Commodities Comment. China Copper Survey: Demand picking up, sentiment remains positive GLOBAL. Feature article. Latest news

MMG. A year of consolidation in 2017 AUSTRALIA/HONG KONG. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Transcription:

AUSTRALIA Lower deficits still in train, arriving late - - - /5 /7-5 -5 Jun-9 Jun- Jun Jun-8 Jun Jun Jun- Revenue recovery remains sluggish 7 5 Australian Federal : Underlying Balance ( of GDP) 5/ Spending restraint to continue / Aug Jun-9 Jun- Jun Jun-8 Jun Jun Jun- 7 5 Australian Federal : Revenues ( of GDP) Aug MYEFO Dec /5 5/ /7 Australian Federal : Spending ( of GDP) 5/ MYEFO Dec /7 Aug /5 Jun-9 Jun- Jun Jun-8 Jun Jun Jun- Source: Treasury, ABS, Macquarie Research, May May Macquarie Securities (Australia) Limited - 7 5 7 5 /7 careful consolidation Event The 7 deficit forecast has widened to $7.bn (. of GDP), with the fiscal and economic projections implying a continued contractionary impulse on the economy. Impact Fiscal policy will remain a drag on the economy in the budget year and through the forward estimates. There has been a slight moderation in pace, but the budget remains on track for a surplus, now predicted in. The budget-neutral nature of the policy changes highlights the lack of macro support from the budget. But the further softening of the communication around policy direction does mean there is unlikely to be a hit to confidence. Outlook This is clearly crafted as an election budget. The policy mix appears carefully calibrated for optimal electoral reception over coming weeks. Additionally, the contains the usual hidden electoral announcements in the decisions taken but not yet announced. Relative to the MYEFO starting point, our assessment is that the is likely to have a relatively neutral impact on the economy from a macro perspective. The three key questions we were looking to for answer from the were: whether it would boost the economy; whether the fiscal impulse delivered would be enough to offset the need for rate cuts and currency depreciation; and the likelihood of downside impacts to confidence. The Government s own economic forecasts, which have been revised and are in line with our expectations (see slide 55 in Link), highlight that the does not imply a substantive pickup in domestic activity until FY8. On our estimates, the government s forecast for public demand the segment of the economy it should know best is relatively subdued, with its contribution to growth remaining -5bp below the long-run average levels. Whilst there appears to be a lot of change across the budget, the net impacts have not significantly altered the bottom line. The budget remains on track for surplus. As the subdued public demand profile highlights, the expenditure constraint is a key component of the fiscal consolidation path. But the continuation of fiscal consolidation through the forward estimate period highlights that the fiscal impulse remains negative. Repairing the budget imposes a cyclical toll on the economy. Over FY5/ and FY/7 the fiscal impulse is marginally smaller than that anticipated at the MYEFO. But this is offset by a slightly larger impact in FY7/8. Bottom line: the budget estimates imply an ongoing lack of macro support, leaving the task of adjustment in the RBA s hands. There s no fiscal catalyst to change our view on rates. The RBA has further work to do. From a confidence perspective, we would not be surprised to see the being relatively well received. However, the communication task over coming days, and weeks through the approaching election campaign ( July poll), can and has in the past undo prospective sentiment boosts. (continued...) Please refer to page for important disclosures and analyst certification, or on our website www.macquarie.com/research/disclosures.

Forecasts Macquarie Wealth Management From a ratings perspective, there would appear to be little to suggest that Australia s AAA rating is under threat. The implies a path back to a structural surplus over the medium term (see figure 8), with the slippage in the surplus date (from FY9/ to FY/) a reflection of weaker near term nominal GDP growth. Net debt remains on track to peak below (see figure ). In our view, a threshold for concern for Australia would be something close to -5, which is below the standard advanced economy threshold, reflecting our larger primary (agriculture & resources) production sector and linkages to China. Fig Public demand set to remain subdued, leaving the economy s rebalancing to the RBA & A$. Fig Marginally gentler fiscal impulse expected in FY5/ & FY/7, offset by larger FY7/8 drag... Australia: Public demand - contribution to GDP growth (year average change, CVM measure) GFCF Consumption Public demand yr Average.. Australian Federal : Fiscal impulse ( of GDP) MYEFO Dec 5 /7.8 (f).8. Macq (f)... -. -. - / / /7 9/ / Jun-8 Jun-9 Jun- Jun Source: Treasury, ABS, Macquarie Research, May Source: Treasury, ABS, Macquarie Research, May - Fig Net debt is expected to peak at 9. of GDP in FY7/8. The budget retains significant fiscal space. Fig Despite an expectation of solid job growth, forecasts for household earnings growth remain weak. 8 8 Australian Federal : Net Debt 5/ ( of GDP) /5 Aug / /7 8 8 - - Employment growth - - - - Jun-9 Jun Jun- Jun Jun Jun-9 Jun-9 Jun-98 Jun- Jun- Jun Jun Jun8 Source: Treasury, ABS, Macquarie Research, May Source: Treasury, ABS, Macquarie Research, May 9 Australia: Employment & Earnings growth (year average change) Compensation of Employees Bus. cycle averages forecasts 9 May

Fig 5 Economic parameter changes (forecast revisions) have added to the bottom line, whilst policy decisions including some not yet announced produced net savings. Source: Treasury, Macquarie Research, May May

Fig Treasury s domestic macro forecasts. Source: Treasury, Macquarie Research, May May

Fig 7 Key budget aggregates. Source: Treasury, Macquarie Research, May Fig 8 Longer-run budget balance projections. Source: Treasury, Macquarie Research, May May 5

Important disclosures: Recommendation definitions Macquarie - Australia/New Zealand Outperform return > in excess of benchmark return Neutral return within of benchmark return Underperform return > below benchmark return Benchmark return is determined by long term nominal GDP growth plus month forward market dividend yield Macquarie Asia/Europe Outperform expected return >+ Neutral expected return from to + Underperform expected return < Macquarie South Africa Outperform expected return >+ Neutral expected return from to + Underperform expected return < Macquarie - Canada Outperform return >5 in excess of benchmark return Neutral return within 5 of benchmark return Underperform return >5 below benchmark return Macquarie - USA Outperform (Buy) return >5 in excess of Russell index return Neutral (Hold) return within 5 of Russell index return Underperform (Sell) return >5 below Russell index return Volatility index definition* This is calculated from the volatility of historical price movements. Very high highest risk Stock should be expected to move up or down in a year investors should be aware this stock is highly speculative. High stock should be expected to move up or down at least in a year investors should be aware this stock could be speculative. Medium stock should be expected to move up or down at least in a year. Low medium stock should be expected to move up or down at least 5 in a year. Low stock should be expected to move up or down at least 5 5 in a year. * Applicable to Asia/Australian/NZ/Canada stocks only Recommendations months Note: Quant recommendations may differ from Fundamental Analyst recommendations Financial definitions All "Adjusted" data items have had the following adjustments made: Added back: goodwill amortisation, provision for catastrophe reserves, IFRS derivatives & hedging, IFRS impairments & IFRS interest expense Excluded: non recurring items, asset revals, property revals, appraisal value uplift, preference dividends & minority interests EPS = adjusted net profit / efpowa* ROA = adjusted ebit / average total assets ROA Banks/Insurance = adjusted net profit /average total assets ROE = adjusted net profit / average shareholders funds Gross cashflow = adjusted net profit + depreciation *equivalent fully paid ordinary weighted average number of shares All Reported numbers for Australian/NZ listed stocks are modelled under IFRS (International Financial Reporting Standards). Recommendation proportions For quarter ending March AU/NZ Asia RSA USA CA EUR Outperform 5. 59.9.7.7.. (for global coverage by Macquarie,.7 of stocks followed are investment banking clients) Neutral. 5.. 9.9. 5. (for global coverage by Macquarie,.79 of stocks followed are investment banking clients) Underperform 5.5 5.. 5. 9. 8.78 (for global coverage by Macquarie,. of stocks followed are investment banking clients) Company-specific disclosures: Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/research/disclosures. Analyst certification: We hereby certify that all of the views expressed in this report accurately reflect our personal views about the subject company or companies and its or their securities. We also certify that no part of our compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. The Analysts responsible for preparing this report receive compensation from Macquarie that is based upon various factors including Macquarie Group Limited (MGL) total revenues, a portion of which are generated by Macquarie Group s Investment Banking activities. General disclosure: This research has been issued by Macquarie Securities (Australia) Limited ABN 58 8, AFSL 897, a Participant of the ASX and Chi-X Australia Pty Limited. This research is distributed in Australia by Macquarie Wealth Management, a division of Macquarie Equities Limited ABN 57 9 AFSL 75 ("MEL"), a Participant of the ASX, and in New Zealand by Macquarie Equities New Zealand Limited ( MENZ ) an NZX Firm. Macquarie Private Wealth s services in New Zealand are provided by MENZ. Macquarie Bank Limited (ABN 8 58 5, AFSL No. 75) ( MBL ) is a company incorporated in Australia and authorised under the Banking Act 959 (Australia) to conduct banking business in Australia. None of MBL, MGL or MENZ is registered as a bank in New Zealand by the Reserve Bank of New Zealand under the Reserve Bank of New Zealand Act 989. Apart from Macquarie Bank Limited ABN 8 58 5 (MBL), any MGL subsidiary noted in this research,, is not an authorised deposit-taking institution for the purposes of the Banking Act 959 (Australia) and that subsidiary s obligations do not represent deposits or other liabilities of MBL. MBL does not guarantee or otherwise provide assurance in respect of the obligations of that subsidiary, unless noted otherwise. This research contains general advice and does not take account of your objectives, financial situation or needs. Before acting on this general advice, you should consider the appropriateness of the advice having regard to your situation. We recommend you obtain financial, legal and taxation advice before making any financial investment decision. This research has been prepared for the use of the clients of the Macquarie Group and must not be copied, either in whole or in part, or distributed to any other person. If you are not the intended recipient, you must not use or disclose this research in any way. If you received it in error, please tell us immediately by return e-mail and delete the document. We do not guarantee the integrity of any e-mails or attached files and are not responsible for any changes made to them by any other person. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any transaction. This research is based on information obtained from sources believed to be reliable, but the Macquarie Group does not make any representation or warranty that it is accurate, complete or up to date. We accept no obligation to correct or update the information or opinions in it. Opinions expressed are subject to change without notice. The Macquarie Group accepts no liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. The Macquarie Group produces a variety of research products, recommendations contained in one type of research product may differ from recommendations contained in other types of research. The Macquarie Group has established and implemented a conflicts policy at group level, which may be revised and updated from time to time, pursuant to regulatory requirements; which sets out how we must seek to identify and manage all material conflicts of interest. The Macquarie Group, its officers and employees may have conflicting roles in the financial products referred to in this research and, as such, may effect transactions which are not consistent with the recommendations (if any) in this research. The Macquarie Group may receive fees, brokerage or commissions for acting in those capacities and the reader should assume that this is the case. The Macquarie Group s employees or officers may provide oral or written opinions to its clients which are contrary to the opinions expressed in this research. Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/disclosures Macquarie Group May